To advance the field of immuno-oncology, we must shift our mindsets and ways of working to embrace agile practices and new levels of knowledge sharing – both within and between organizations.
By Peter Sandor, @AstellasUScellandgene.com/doc/igniting-i…
Anna Rose Welch shares a few of the actionable takeaways she walked away with from the ARM/ASGCT potency assay working session in the hopes they will be a complementary exploration of the analytical challenge impacting every ATMP company.
cellandgene.com/doc/overcoming…
While this list includes some of my favorite editorial from 2022, it’s not even close to being as extensive as I’d like. Why is that? Our library of content is so deep and so rich, I couldn’t possibly share and recap all of it with you in one article.
cellandgene.com/doc/my-top-edi…
A judge ruled #stemcells removed from a patient, centrifuged, & reinjected into a patient are not drugs & do not require FDA premarket approval. FDA filed an appeal but until it's heard the decision may have consequences for stem cell therapy companies.
cellandgene.com/doc/the-regula…
Here, I offer my biggest takeaways from a recent ARM/ASGCT workshop on one of the most popular topics to gossip about both in and outside the analytical labs: Potency assays.
cellandgene.com/doc/cell-and-g…
Leveraging human genetics data early in the drug discovery process to inform target prioritization is a powerful approach to mitigate risk and increase the likelihood of advancing safe therapies that transform patient’s lives.
By Vor Bio
cellandgene.com/doc/leveraging…
To advance the field of immuno-oncology, we must shift our mindsets and ways of working to embrace agile practices and new levels of knowledge sharing – both within and between organizations.
By Peter Sandor, @AstellasUScellandgene.com/doc/igniting-i…
Anna Rose Welch shares a few of the actionable takeaways she walked away with from the ARM/ASGCT potency assay working session in the hopes they will be a complementary exploration of the analytical challenge impacting every ATMP company.
cellandgene.com/doc/overcoming…
While this list includes some of my favorite editorial from 2022, it’s not even close to being as extensive as I’d like. Why is that? Our library of content is so deep and so rich, I couldn’t possibly share and recap all of it with you in one article.
cellandgene.com/doc/my-top-edi…
A judge ruled #stemcells removed from a patient, centrifuged, & reinjected into a patient are not drugs & do not require FDA premarket approval. FDA filed an appeal but until it's heard the decision may have consequences for stem cell therapy companies.
cellandgene.com/doc/the-regula…
In part one of this two-part series, as seen in Life Science Leader, experts from Kite Pharma, Novartis Gene Therapies, and SwanBio Therapeutics weigh in on understanding how to drive down COGS and expedite commercial-scale manufacturing in the CGT space.
cellandgene.com/doc/how-to-red…
To figure out what the future holds for companies in the RNA sector of the ATMP space, I sat down with four executives to discuss their expectations. As you’ll note, there is no shortage of work facing the RNA therapeutics industry in the year(s) ahead.
cellandgene.com/doc/mrna-rna-t…
Here, I offer my biggest takeaways from a recent ARM/ASGCT workshop on one of the most popular topics to gossip about both in and outside the analytical labs: Potency assays.
cellandgene.com/doc/cell-and-g…
Leveraging human genetics data early in the drug discovery process to inform target prioritization is a powerful approach to mitigate risk and increase the likelihood of advancing safe therapies that transform patient’s lives.
By Vor Bio
cellandgene.com/doc/leveraging…
10K Followers 2K FollowingAdvancing knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
2K Followers 180 FollowingGlobal device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. #CED #CLPT #Nsgy #DBS #LITT #GeneTherapy #SmartFlow
4K Followers 1K FollowingEnsuring Pennsylvania is the U.S. hub for the life sciences by creating a business and public policy environment which fosters life sciences growth and success.
1K Followers 2K FollowingStatistician and computational biologist; alum @maehrlab, @cahanlab, @alexisjbattle lab. Views are not those of my employer. He/him. https://t.co/jaMuFiHjk0
592 Followers 4K FollowingSynthetic biology, cell and gene therapy. Member of the Leonard Lab at Northwestern University. Public transit and techno enthusiast. Views are my own.
618 Followers 1K FollowingCytosurge uses its FluidFM® tech for single-cell manipulation and CRISPR. The vision is to turn genetic designs into cures, bridging design and manufacturing.
3K Followers 7K Following🧬 Clinical vignettes to sharpen your medical genetic diagnostic skills - great for exam prep (such as ABMGG, ABGC) and continuing certification. 🩺
348 Followers 847 Followingbiomedical scientist, immunologist, gene & cell therapies for oncology and genetic diseases, opinions are my own and not those of my employer
83 Followers 427 FollowingManager of Corporate Affairs for Antech Diagnostics, a Mars Petcare company
Previously Media Relations at @LifeSciComms | Public Relations at @EmersonSOC
134 Followers 136 FollowingPostDoc Researcher in Genetics and Plant Biotechnology 🧬🌱at DISSPA @uniba. Member of @COST_PlantEd and SIGA society. #genomeediting #CRISPR #markerSSR 🍅🌾
806 Followers 990 FollowingCOEPTIS (NASDAQ: $COEP) is a biopharmaceutical & AI technology company focused on development in treatments for cancer, autoimmune, and infectious diseases
1K Followers 5K Following$BTI $PM $MO | The great re-nicotinization experiment is upon us! RRPs have reignited the world's repressed desire for nicotine. 🤯✌️ THE FACTORY IS HUMMING
4K Followers 1K FollowingEnsuring Pennsylvania is the U.S. hub for the life sciences by creating a business and public policy environment which fosters life sciences growth and success.
2K Followers 752 FollowingOncologist and immunologist, believing that the cure lies within the immune system. CEO, Drug developer, dog lover, Philly sports fan and mom. Tweets are my own
2K Followers 3K Following#Bioethics & #SciPolicy @sppgatech
Associate Dean @GTLiberalArts @GeorgiaTech
#CellManufacturing @CMaT_ERC
Views my own, Not my Employer's
Also on BlueSky
40K Followers 3K Following#NORD has been the voice of the U.S. #RareDisease community for 40+ years strong. Official U.S. sponsor of #RareDiseaseDay. On Bluesky at @ https://t.co/D7PIT4k0Py
293 Followers 311 FollowingBioBreak brings biotech, pharma, medtech, diagnostic and venture capital executives together to foster a stronger environment for the life sciences.
943 Followers 7 FollowingTmunity is now part of Kite, a Gilead Company. Kite’s singular focus is cell therapy to treat and potentially cure cancer. Follow @KitePharma for updates.
340K Followers 59 FollowingReceive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or [email protected]. Privacy Policy - https://t.co/K2nAJlm94m.